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The focus of the 16th Bethesda Conference is the athlete 
with an underlying primary cardiovascular abnormality, and 
its goal is to arrive at consensus opinions for prudent rec•
ommendations regarding the eligibility of such athletes for 
competition. Before the convening of this Conference, no 
formal guidelines were available for this purpose, and such 
recommendations to athletes were based largely on the in•
tuition of the individual physician. To accomplish our ob•
jectives, we have tried to determine which cardiovascular 
abnormalities (as well as their severity) would place the 
athlete at risk for sudden death, life-threatening cardiovas•
cular alterations or disease progression. 
For the purposes of this Conference, we have defined 
the competitive athlete as one who participates in an orga•
nized team or individual sport that requires regular com•
petition against others as a central component, places a high 
premium on excellence and achievement and requires vig•
orous training in a systematic fashion. Another important 
facet of competitive activity is that the athlete may not be 
able to use proper judgment in determining whether to ex•
tricate himself or herself from the competitive event, should 
that become necessary. For example, warning symptoms of 
cardiovascular distress, such as lightheadedness, fatigue or 
chest discomfort occurring during competition may be dif•
ficult to reliably distinguish from normal sensations due to 
the physical activity itself; furthermore, the athlete may not 
immediately terminate the physical exertion even when the 
need to do so is perceived, because of the unique circum•
stances and pressures of organized athletic competition. We 
have considered the athlete to be "competitive" regardless 
of age; he or she could participate in sports at the youth 
(less than 12 years old), interscholastic, intercollegiate, 
professional or masters (greater than 40 years old) levels. 
The recommendations of this Conference were not formu-
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lated with the purely recreational athlete in mind; they also 
do not pertain to participation in cardiac rehabilitation 
programs. 
These considerations helped formulate some of our work•
ing definitions, although we recognize that these definitions 
are arbitrary and that many individuals may participate in 
"recreational" sports in a truly competitive fashion. We 
should also emphasize that the risk of sudden death in any 
individual athlete with cardiovascular disease is low; fur•
thermore, the number of athletes who die prematurely every 
year is relatively small, particularly when the large number 
of individuals competing in sports is considered. Although 
sudden death in the athlete may not be a major public health 
problem, we believe nevertheless that such catastrophes have 
an enonnous impact on the public consciousness and on the 
attitudes of the medical profession. In addition to the prob•
lem of sudden death, the recommendations of this Confer•
ence are also concerned with the impact that athletic com•
petition may have on the symptomatic and functional 
progression of certain cardiovascular diseases. 
The recommendations contained in this report must be 
placed in perspective. First, there are few definitive data 
demonstrating either that strenuous exertion predisposes to 
a death which otherwise would not have occurred or the 
corollary-that withdrawal from competitive athletics will 
prolong life. Hence, it is possible that our recommendations 
may occasionally cause some individuals to withdraw from 
athletics unnecessarily. This, of course, would be extremely 
unfortunate because athletes may potentially derive consid•
erable self-assurance and confidence, as well as physical 
well-being, from these activities. The primary impetus and 
justification for this Conference, however, is the general 
perception, largely intuitive, that individuals with certain 
organic or structural heart diseases are at increased risk of 
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sudden death (or more rapid disease progression) when ex•
posed to the stress of strenuous and competitive sports. 
Admittedly, therefore, this Bethesda Conference does not 
constitute a scientific document iri the strictest sense but its 
recommendations are necessarily based largely on the pnic•
tice of the "art of medicine." Nevertheless, it is the ob•
jective of this Conference to ascertain when "reasonable 
certainty" of risk for sudden death, life-threatening cardio•
vascular alterations or disease progression applies to athletes 
with particular cardiovascular abnormalities and to develop 
relevant recommendations. 
Second, we also realize that not all competitive sports 
involve equal types and intensities of physical activity (I). 
Fot example, competitive dist~nce running obviously differs 
substaritially from golfing or bowling. Indeed, some youth 
sports, although competitive; do not require high intensity 
exercise (for example, little leaglle baseball). Even within 
the same sport, variability in the degree of physical exertion 
may exist at different positions. In football, a running back 
is exposed to far greater exertion and stress than a place•
kicker is. However, it is difficult to standardize the varia•
bility in grades of physical intensity inherent in different 
sports (or in various positions within a given sport) because 
of the differences in motivational attitu~es among individual 
athletes and also in the training demands made on the athlete 
by different coaches. For example, it accomplishes little to 
confine a football player to placekicking during games when 
the coach requires that athlete to participate in the same 
practice regimen as all the other team members. 
Although the emphasis of the recommendations of this 
Bethesda Conference is on the risk of sudden death, life•
threatening cardiovascular alterations or disease progres•
sion, other factors may also be considered in removing an 
athlete from competition or training. For example, cardio•
vascular disease associated with syncop~ or lightheadedness 
may place the athlete participating in weight lifting or down•
hill skiing at risk of serious btldily injury. These symptoms 
occurring in athletes participating in other sports (such as 
auto racing) could also endanger the well-being of other 
competitors or even spectators. Such complexities underline 
the fact that it is the physician who ultimately must decide 
on recommendations for the individual athlete. 
We are also cognizant that no, official standard or cen•
tralized mechanism exists in the United States for making 
recommendations regarding the eligibility of athletes with 
cardiovascular abnormalities to participate in competitive 
athletics. Ideally, the team physician would accept the ul•
timate responsibility for such decisions. However, this is 
often impractical because many athletes do not have access 
to a team physican; in addition, those physicians are rarely 
either cardiovascular specialists or experts in identifying or 
assessing the significance of cardiovascular disease in ath•
letes. In professional sports (and some would contend, in•
tercollegiate sports, as well), the mechanism by which elite 
athletes with cardiovascular abnormalities may be disqual-
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ified from competition is often complicated further by other 
pressures (for example, the monetary value of the athlete, 
the extreme emphasis on competitive achievement and the 
desire for financial profit on the part of the organization 
with which the athlete is associated). 
Nevertheless, certain physicians find themselves respon•
sible for deciding whether a given athlete should continue 
to compete when cardiovascular abnormalities ate identi•
fied. It is our view that the physician's primary responsibility 
is to make recommendations to the athletes, and that the 
physician need not be solely responsible for the ~Itimate 
decision of whether an athlete is permitted to compete. This 
latter issue involves complex medical and legal ptinCiples 
(2) aI1d is complicated further by the fact that many decisions 
regarding disqualification from sports involve circumstances 
in which definitive scientific answers are conspicuously 
lacking. In this situation, the athlete (orthe athlete's family) 
may be in an advantageous position to take the primary 
responsibility for such a decision. Often it is the parents or 
close relatives of the athlete who, after being apprised of 
the situation by the physician, are best able to evaluate the 
nature and severity of the proposed athletic activity on a 
day to day basis. 
Finally, practical limitations prohibited this Bethesda 
Conference from analyzing all of the important issues related 
to competitive athletes with cardiovascular abnormalities. 
For example, this Conference develops recommendaiions 
for the eligibility of the athlete who has been identified as 
probably or definitely having cardiovascular disease; how•
ever, time constraints made it impossible for the conferees 
to formulate detailed descriptions of the procedures by which 
each congenital or acquired cardiovascular lesion may be 
identified clinically in a given athlete. Thus, the complex 
issues surrounding preparticipation screening for cardio•
vascular disease were deemed to be beyond the practical 
scope of the Conference. Hence, the orientation of this 
Conference is the formulation of recommendations for the 
competitive athlete who has already been ident(fied as hav•
ing a cardiovascular abnormality by whatever means. The 
Conference also does not discuss the management of athletes 
with cardiovascular disease in the period after their dis•
qualification from competitive sports, such as the selection 
of alternate physical activities. Despite these defined limits, 
we hope that the recommendations of the 16th Bethesda 
Conference WIll be useful for the physician in formulating 
decisions, even if they provide only partial answers to com•
plex questions. 
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